More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/MediaLibrary/Images/2026-01-22-14-35-05-958-69723599b0183f59ca4b3580.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-10-21-15-40-35-002-6ad8dcf3594ea8e6e3adb236.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-09-09-14-11-57-927-6aa1692d313dbadbe82c05c3.jpg)